A Comparison of the Effect of High-dose Oral and Intravenous Proton Pump Inhibitor on the Prevention of Rebleeding after Endoscopic Treatment of Bleeding Peptic Ulcers / 대한소화기내시경학회지
Korean Journal of Gastrointestinal Endoscopy
;
: 6-11, 2006.
Article
in Korean
| WPRIM
| ID: wpr-104185
ABSTRACT
BACKGROUND/AIMS:
The use of proton pump inhibitor (PPI) prevents rebleeding by elevating the intragastric pH in patients with bleeding peptic ulcers after hemostasis has been achieved. We assessed if high-dose oral pantoprazole is as effective as high-dose intravenous pantoprazole for their ability to prevent rebleeding after having achieved initial hemostasis in patients with active bleeding or nonbleeding visible vessels.METHODS:
Thirty eight patients with bleeding peptic ulcers who had achieved initial hemostasis were enrolled in this randomized controlled trial. In the high-dose oral pantoprazole group (n=19), 40 mg of pantoprazole was given orally twice daily for 5 days. In the high-dose intravenous pantoprazole group (n=19), an 80 mg intravenous bolus of pantoprazole was given; this was followed by 8 mg/hour of continuous infusion daily for 3 days. Thereafter, 40 mg of pantoprazole was given orally once daily for 8 weeks.RESULTS:
The two groups were similar with respect to all the background variables. Rebleeding occurred in 2 patients (10.5%) in the intravenous group and in 1 patient in the oral group (5.3%) by day 30 after enrollment (p=1.000). There was no significant difference in terms of the number of therapeutic endoscopic sessions (1 vs. 1.13+/-0.52), the surgery (0% vs. 0%), the bleeding related mortality (0% vs. 0%), and the mean number of units of transfused blood.CONCLUSIONS:
The high-dose oral pantoprazole is as effective as an intravenous administration in reducing rebleeding episodes in patients with bleeding peptic ulcers after successful endoscopic therapy.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Peptic Ulcer
/
Protons
/
Peptic Ulcer Hemorrhage
/
Mortality
/
Proton Pumps
/
Administration, Intravenous
/
Hemorrhage
/
Hemostasis
/
Hydrogen-Ion Concentration
Type of study:
Controlled clinical trial
/
Prognostic study
Limits:
Humans
Language:
Korean
Journal:
Korean Journal of Gastrointestinal Endoscopy
Year:
2006
Type:
Article
Similar
MEDLINE
...
LILACS
LIS